mizolastine has been researched along with Conjunctivitis, Allergic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ciprandi, G; Cirillo, I; Vizzaccaro, A | 1 |
Bachert, C; Brostoff, J; Murrieta, M; Scadding, GK; Stalla-Bourdillon, A; Tasman, J | 1 |
Attali, P; Ben-Soussen, P; Daele, J; Sabbah, A; Wade, AG | 1 |
Bachert, C; Murrieta-Aguttes, M; Scadding, GK; Tasman, AJ | 1 |
Bachert, C; Margari, P; Murrieta-Aguttes, M; Santoni, JP; Vovolis, V | 1 |
4 trial(s) available for mizolastine and Conjunctivitis, Allergic
Article | Year |
---|---|
Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
Topics: Adult; Allergens; Anti-Allergic Agents; Benzimidazoles; Conjunctivitis, Allergic; Cytokines; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Interleukin-1; Interleukin-6; Male; Nasal Provocation Tests; Parietaria; Pollen; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Terfenadine; Tumor Necrosis Factor-alpha | 2004 |
Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group.
Topics: Adult; Asthma; Benzimidazoles; Cellulitis; Central Nervous System Diseases; Conjunctivitis, Allergic; Dizziness; Double-Blind Method; Female; Gastrointestinal Diseases; Headache; Histamine H1 Antagonists; Humans; Leukopenia; Male; Middle Aged; Nasal Obstruction; Placebos; Respiratory Tract Diseases; Rhinitis, Allergic, Perennial; Sleep Stages; Treatment Outcome | 1998 |
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Safety; Time Factors; Treatment Outcome | 1999 |
Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group.
Topics: Adult; Benzimidazoles; Conjunctivitis, Allergic; Double-Blind Method; Europe; Female; Histamine H1 Antagonists; Humans; Male; Placebos; Rhinitis, Allergic, Perennial; Safety; Time Factors | 1999 |
1 other study(ies) available for mizolastine and Conjunctivitis, Allergic
Article | Year |
---|---|
Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).
Topics: Adolescent; Adult; Benzimidazoles; Child; Cohort Studies; Conjunctivitis, Allergic; Europe; Female; Histamine H1 Antagonists; Humans; Incidence; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2001 |